[Form 4] Jasper Therapeutics, Inc. Insider Trading Activity
Clover Health Investments (CLOV) 鈥� Form 4 insider filing: CEO and Director Andrew Toy reported an automatic share disposition on 07/01/2025 related to the vesting of previously granted RSUs. A total of 308,950 Class A common shares were withheld to satisfy tax obligations (transaction code 鈥淔鈥�) at a reference price of $2.75. Following the withholding, Toy鈥檚 direct beneficial ownership stands at 10,560,047 shares. The RSU award, originally granted on 01/01/2023 and reported on 01/04/2023, vests quarterly in equal 6.25% installments through 01/01/2027, contingent upon continued service.
The filing reflects a routine, non-open-market administrative transaction rather than an elective sale, and does not indicate a change in Toy鈥檚 long-term ownership intent. No derivative securities or additional open-market trades were reported.
Clover Health Investments (CLOV) 鈥� Comunicazione interna Form 4: Il CEO e Direttore Andrew Toy ha segnalato una cessione automatica di azioni il 01/07/2025 relativa al consolidamento di RSU precedentemente assegnate. Un totale di 308.950 azioni ordinarie di Classe A 猫 stato trattenuto per adempiere agli obblighi fiscali (codice transazione 鈥淔鈥�) al prezzo di riferimento di 2,75$. Dopo questa trattenuta, la propriet脿 diretta di Toy ammonta a 10.560.047 azioni. Il premio RSU, originariamente concesso il 01/01/2023 e comunicato il 04/01/2023, si consolida trimestralmente in quote uguali del 6,25% fino al 01/01/2027, subordinato al mantenimento del servizio.
La comunicazione riflette una transazione amministrativa di routine, non di mercato aperto, piuttosto che una vendita volontaria, e non indica un cambiamento nell鈥檌ntento di possesso a lungo termine di Toy. Non sono stati riportati strumenti derivati o ulteriori operazioni di mercato aperto.
Clover Health Investments (CLOV) 鈥� Presentaci贸n interna Formulario 4: El CEO y Director Andrew Toy report贸 una disposici贸n autom谩tica de acciones el 01/07/2025 relacionada con la consolidaci贸n de RSU previamente otorgadas. Un total de 308,950 acciones comunes Clase A fueron retenidas para cumplir con obligaciones fiscales (c贸digo de transacci贸n 鈥淔鈥�) a un precio de referencia de $2.75. Tras la retenci贸n, la propiedad directa de Toy es de 10,560,047 acciones. La concesi贸n de RSU, originalmente otorgada el 01/01/2023 y reportada el 04/01/2023, se consolida trimestralmente en cuotas iguales del 6.25% hasta el 01/01/2027, condicionado al servicio continuo.
La presentaci贸n refleja una transacci贸n administrativa rutinaria, no en mercado abierto, m谩s que una venta voluntaria, y no indica un cambio en la intenci贸n de propiedad a largo plazo de Toy. No se reportaron valores derivados ni operaciones adicionales en mercado abierto.
Clover Health Investments (CLOV) 鈥� 雮措秬鞛� 鞁犼碃靹� Form 4: CEO 瓴� 鞚挫偓鞚� Andrew Toy電� 2025雲� 7鞗� 1鞚检棎 鞚挫爠鞐� 攵�鞐悳 RSU鞚� 氩犾姢韺呹臣 甏�霠悳 鞛愲彊 欤检嫕 觳橂秳鞚� 氤搓碃頄堨姷雼堧嫟. 齑� 308,950欤� 韥措灅鞀� A 氤错喌欤缄皜 靹戈笀 雮╇秬 鞚橂毳� 於╈”頃橁赴 鞙勴暣 鞗愳矞歆曥垬霅橃棃鞙茧┌(瓯半灅 旖旊摐 鈥淔鈥�), 旮办 臧�瓴╈潃 2.75雼煬鞓�鞀惦媹雼�. 鞗愳矞歆曥垬 頉� Toy鞚� 歆侅爲 鞁れ唽鞙� 欤检嫕 靾橂姅 10,560,047欤�鞛呺媹雼�. RSU 靾橃棳電� 2023雲� 1鞗� 1鞚检棎 觳橃潓 攵�鞐悩鞐堦碃 2023雲� 1鞗� 4鞚检棎 氤搓碃霅橃棃鞙茧┌, 2027雲� 1鞗� 1鞚缄箤歆� 歆�靻� 攴茧毳� 臁瓣贝鞙茧 攵勱赴氤勲 霃欖澕頃� 6.25%鞌� 氩犾姢韺呺惄雼堧嫟.
鞚� 鞁犼碃電� 靹犿儩鞝� 毵る弰臧� 鞎勲媽 鞚检儊鞝侅澑 牍勱车臧� 頄夓爼 瓯半灅毳� 氚橃榿頃橂┌, Toy鞚� 鞛リ赴 靻岇湢 鞚橂弰 氤�瓴届潉 雮橅儉雮挫 鞎婌姷雼堧嫟. 韺岇儩 歃濌秾鞚措倶 於旉皜 瓿店皽 鞁滌灔 瓯半灅電� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
Clover Health Investments (CLOV) 鈥� D茅claration d鈥檌niti茅 Formulaire 4 : Le PDG et Directeur Andrew Toy a d茅clar茅 une cession automatique d鈥檃ctions le 01/07/2025 li茅e 脿 l鈥檃cquisition progressive d鈥檜nit茅s d鈥檃ctions restreintes (RSU) pr茅c茅demment attribu茅es. Un total de 308 950 actions ordinaires de Classe A a 茅t茅 retenu pour satisfaire aux obligations fiscales (code de transaction 芦 F 禄) au prix de r茅f茅rence de 2,75 $. Apr猫s cette retenue, la d茅tention directe de Toy s鈥櫭﹍猫ve 脿 10 560 047 actions. L鈥檃ttribution des RSU, initialement accord茅e le 01/01/2023 et d茅clar茅e le 04/01/2023, se consolide trimestriellement par tranches 茅gales de 6,25 % jusqu鈥檃u 01/01/2027, sous r茅serve de la poursuite du service.
La d茅claration refl猫te une transaction administrative de routine, non r茅alis茅e sur le march茅 ouvert, plut么t qu鈥檜ne vente volontaire, et n鈥檌ndique aucun changement dans l鈥檌ntention de d茅tention 脿 long terme de Toy. Aucun titre d茅riv茅 ni transaction suppl茅mentaire sur le march茅 ouvert n鈥檃 茅t茅 signal茅.
Clover Health Investments (CLOV) 鈥� Insider-Meldung Form 4: CEO und Direktor Andrew Toy meldete am 01.07.2025 eine automatische Aktienver盲u脽erung im Zusammenhang mit der Vesting von zuvor gew盲hrten RSUs. Insgesamt wurden 308.950 Class-A-Stammaktien zur Erf眉llung steuerlicher Verpflichtungen einbehalten (Transaktionscode 鈥濬鈥�) zu einem Referenzpreis von 2,75 $. Nach der Einbehaltung besitzt Toy direkt 10.560.047 Aktien. Die RSU-Zuteilung, urspr眉nglich am 01.01.2023 gew盲hrt und am 04.01.2023 gemeldet, vestet viertelj盲hrlich in gleichen 6,25%-Anteilen bis zum 01.01.2027, vorbehaltlich fortgesetzter Dienstzeit.
Die Meldung spiegelt eine routinem盲脽ige, nicht am offenen Markt erfolgte Verwaltungstransaktion wider, keine freiwillige Ver盲u脽erung, und deutet nicht auf eine 脛nderung von Toys langfristiger Eigentumsabsicht hin. Es wurden keine Derivate oder zus盲tzlichen offenen Markttransaktionen gemeldet.
- CEO retains a significant ownership stake of 10.56 million shares, supporting management鈥搒hareholder alignment.
- 308,950 shares were removed from the CEO鈥檚 beneficial ownership, which some investors may initially view as insider selling even though it is tax-related.
Insights
TL;DR: Routine tax-withholding; CEO still holds 10.56 M shares鈥攏eutral signal.
The Form 4 discloses an administrative disposition (code F) of 308,950 shares to cover payroll taxes from quarterly RSU vesting. Such transactions are non-discretionary and do not involve open-market selling, limiting any negative interpretation. Toy鈥檚 remaining stake is sizeable, implying continued alignment with shareholders. No new share grants, option exercises, or open-market purchases/sales were reported, and there is no immediate balance-sheet or dilution impact because the shares are withheld and typically retired by the company. Overall impact to valuation or sentiment is minimal.
Clover Health Investments (CLOV) 鈥� Comunicazione interna Form 4: Il CEO e Direttore Andrew Toy ha segnalato una cessione automatica di azioni il 01/07/2025 relativa al consolidamento di RSU precedentemente assegnate. Un totale di 308.950 azioni ordinarie di Classe A 猫 stato trattenuto per adempiere agli obblighi fiscali (codice transazione 鈥淔鈥�) al prezzo di riferimento di 2,75$. Dopo questa trattenuta, la propriet脿 diretta di Toy ammonta a 10.560.047 azioni. Il premio RSU, originariamente concesso il 01/01/2023 e comunicato il 04/01/2023, si consolida trimestralmente in quote uguali del 6,25% fino al 01/01/2027, subordinato al mantenimento del servizio.
La comunicazione riflette una transazione amministrativa di routine, non di mercato aperto, piuttosto che una vendita volontaria, e non indica un cambiamento nell鈥檌ntento di possesso a lungo termine di Toy. Non sono stati riportati strumenti derivati o ulteriori operazioni di mercato aperto.
Clover Health Investments (CLOV) 鈥� Presentaci贸n interna Formulario 4: El CEO y Director Andrew Toy report贸 una disposici贸n autom谩tica de acciones el 01/07/2025 relacionada con la consolidaci贸n de RSU previamente otorgadas. Un total de 308,950 acciones comunes Clase A fueron retenidas para cumplir con obligaciones fiscales (c贸digo de transacci贸n 鈥淔鈥�) a un precio de referencia de $2.75. Tras la retenci贸n, la propiedad directa de Toy es de 10,560,047 acciones. La concesi贸n de RSU, originalmente otorgada el 01/01/2023 y reportada el 04/01/2023, se consolida trimestralmente en cuotas iguales del 6.25% hasta el 01/01/2027, condicionado al servicio continuo.
La presentaci贸n refleja una transacci贸n administrativa rutinaria, no en mercado abierto, m谩s que una venta voluntaria, y no indica un cambio en la intenci贸n de propiedad a largo plazo de Toy. No se reportaron valores derivados ni operaciones adicionales en mercado abierto.
Clover Health Investments (CLOV) 鈥� 雮措秬鞛� 鞁犼碃靹� Form 4: CEO 瓴� 鞚挫偓鞚� Andrew Toy電� 2025雲� 7鞗� 1鞚检棎 鞚挫爠鞐� 攵�鞐悳 RSU鞚� 氩犾姢韺呹臣 甏�霠悳 鞛愲彊 欤检嫕 觳橂秳鞚� 氤搓碃頄堨姷雼堧嫟. 齑� 308,950欤� 韥措灅鞀� A 氤错喌欤缄皜 靹戈笀 雮╇秬 鞚橂毳� 於╈”頃橁赴 鞙勴暣 鞗愳矞歆曥垬霅橃棃鞙茧┌(瓯半灅 旖旊摐 鈥淔鈥�), 旮办 臧�瓴╈潃 2.75雼煬鞓�鞀惦媹雼�. 鞗愳矞歆曥垬 頉� Toy鞚� 歆侅爲 鞁れ唽鞙� 欤检嫕 靾橂姅 10,560,047欤�鞛呺媹雼�. RSU 靾橃棳電� 2023雲� 1鞗� 1鞚检棎 觳橃潓 攵�鞐悩鞐堦碃 2023雲� 1鞗� 4鞚检棎 氤搓碃霅橃棃鞙茧┌, 2027雲� 1鞗� 1鞚缄箤歆� 歆�靻� 攴茧毳� 臁瓣贝鞙茧 攵勱赴氤勲 霃欖澕頃� 6.25%鞌� 氩犾姢韺呺惄雼堧嫟.
鞚� 鞁犼碃電� 靹犿儩鞝� 毵る弰臧� 鞎勲媽 鞚检儊鞝侅澑 牍勱车臧� 頄夓爼 瓯半灅毳� 氚橃榿頃橂┌, Toy鞚� 鞛リ赴 靻岇湢 鞚橂弰 氤�瓴届潉 雮橅儉雮挫 鞎婌姷雼堧嫟. 韺岇儩 歃濌秾鞚措倶 於旉皜 瓿店皽 鞁滌灔 瓯半灅電� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.
Clover Health Investments (CLOV) 鈥� D茅claration d鈥檌niti茅 Formulaire 4 : Le PDG et Directeur Andrew Toy a d茅clar茅 une cession automatique d鈥檃ctions le 01/07/2025 li茅e 脿 l鈥檃cquisition progressive d鈥檜nit茅s d鈥檃ctions restreintes (RSU) pr茅c茅demment attribu茅es. Un total de 308 950 actions ordinaires de Classe A a 茅t茅 retenu pour satisfaire aux obligations fiscales (code de transaction 芦 F 禄) au prix de r茅f茅rence de 2,75 $. Apr猫s cette retenue, la d茅tention directe de Toy s鈥櫭﹍猫ve 脿 10 560 047 actions. L鈥檃ttribution des RSU, initialement accord茅e le 01/01/2023 et d茅clar茅e le 04/01/2023, se consolide trimestriellement par tranches 茅gales de 6,25 % jusqu鈥檃u 01/01/2027, sous r茅serve de la poursuite du service.
La d茅claration refl猫te une transaction administrative de routine, non r茅alis茅e sur le march茅 ouvert, plut么t qu鈥檜ne vente volontaire, et n鈥檌ndique aucun changement dans l鈥檌ntention de d茅tention 脿 long terme de Toy. Aucun titre d茅riv茅 ni transaction suppl茅mentaire sur le march茅 ouvert n鈥檃 茅t茅 signal茅.
Clover Health Investments (CLOV) 鈥� Insider-Meldung Form 4: CEO und Direktor Andrew Toy meldete am 01.07.2025 eine automatische Aktienver盲u脽erung im Zusammenhang mit der Vesting von zuvor gew盲hrten RSUs. Insgesamt wurden 308.950 Class-A-Stammaktien zur Erf眉llung steuerlicher Verpflichtungen einbehalten (Transaktionscode 鈥濬鈥�) zu einem Referenzpreis von 2,75 $. Nach der Einbehaltung besitzt Toy direkt 10.560.047 Aktien. Die RSU-Zuteilung, urspr眉nglich am 01.01.2023 gew盲hrt und am 04.01.2023 gemeldet, vestet viertelj盲hrlich in gleichen 6,25%-Anteilen bis zum 01.01.2027, vorbehaltlich fortgesetzter Dienstzeit.
Die Meldung spiegelt eine routinem盲脽ige, nicht am offenen Markt erfolgte Verwaltungstransaktion wider, keine freiwillige Ver盲u脽erung, und deutet nicht auf eine 脛nderung von Toys langfristiger Eigentumsabsicht hin. Es wurden keine Derivate oder zus盲tzlichen offenen Markttransaktionen gemeldet.
FAQ
What did Clover Health's Form 4 report about CEO Andrew Toy?
Was the transaction an open-market sale of CLOV shares?
How many Clover Health shares does the CEO hold after the transaction?
What is the vesting schedule for the CEO's RSUs?
Does this Form 4 filing materially affect Clover Health鈥檚 share count?
